Search Within

Eric J Sherman

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (40)
  2. Meeting Abstract (35)
Groups
  1. Department of Medicine (75)
  2. Epidemiology and Biostatistics (75)
  3. Head and Neck Service (75)
  4. Solid Tumor Oncology Division (75)
  5. Biostatistics Service (67)
  6. Radiation Oncology, Department of (52)

More Groups

People
  1. David Pfister (55)
  2. Nancy Lee (49)
  3. Zhigang Zhang (34)
  4. Alan Ho (29)
  5. Nadeem Riaz (29)
  6. Lara Dunn (25)

More People

Years
  1. 2024 (9)
  2. 2023 (3)
  3. 2022 (4)
  4. 2021 (6)
  5. 2020 (4)
  6. 2019 (5)

More Years

Publications
  1. Journal of Clinical Oncology (23)
  2. International Journal of Radiation Oncology, Biology, Physics (19)
  3. Annals of Oncology (5)
  4. Cancer (4)
  5. Head & Neck (4)
  6. Laryngoscope (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (23)
  2. Elsevier Inc. (20)
  3. Wiley Blackwell (8)
  4. Oxford University Press (7)
  5. John Wiley & Sons, Inc. (4)
  6. American Association for Cancer Research (3)

More Publishers

Results (75)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Any day, split halfway: Flexibility in scheduling high-dose cisplatin - A large retrospective review from a high-volume cancer center
    Journal Article

    Kang, J. J.; Tchekmedyian, V.; Mohammed, N.; Rybkin, A.; Kitpanit, S.; Fan, M.; Wang, H.; Lobaugh, S. M.; Zhang, Z.; Lee, A.; more...
    International Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Randomized phase II trial of nivolumab with stereotactic body radiotherapy versus nivolumab alone in metastatic head and neck squamous cell carcinoma
    Journal Article

    McBride, S.; Sherman, E.; Tsai, C. J.; Baxi, S.; Aghalar, J.; Eng, J.; Zhi, W. I.; McFarland, D.; Michel, L. S.; Young, R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Split high-dose cisplatin: An alternate high-dose cisplatin administration schedule for definitive chemoradiation in oropharyngeal cancer
    Meeting Abstract

    Kang, J. J.; Tchekmedyian, V.; Fan, M.; Wang, H.; Kitpanit, S.; Mohamed, N.; Rybkin, A.; Lee, A.; Chen, L.; Yu, Y.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers
    Meeting Abstract

    Burman, B.; Sherman, E. J.; Kriplani, A.; Michel, L. S.; Dunn, L.; Fetten, J. V.; Warner, E.; Grewal, R. K.; Sabra, M.; Tuttle, R. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancer
    Journal Article

    Beckham, T. H.; Barney, C.; Healy, E.; Wolfe, A. R.; Branstetter, A.; Yaney, A.; Riaz, N.; McBride, S. M.; Tsai, C. J.; Kang, J.; more...
    International Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Outcomes of surgery and postoperative radiation therapy in managing medullary thyroid carcinoma
    Journal Article

    Groen, A. H.; Beckham, T. H.; Links, T. P.; Goldman, D. A.; Sherman, E. J.; Tuttle, M. M.; Bijl, H. P.; Wong, R. J.; Plukker, J. T. M.; Lee, N. Y.; more...
    Journal of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • Long-term survival in patients with metastatic head and neck squamous cell carcinoma treated with metastasis-directed therapy
    Journal Article

    Beckham, T. H.; Leeman, J. E.; Xie, P.; Li, X.; Goldman, D. A.; Zhang, Z.; Sherman, E.; McBride, S.; Riaz, N.; Lee, N.; more...
    British Journal of Cancer (2019)

    Fulltext@MSK | Save
  • A retrospective analysis of cisplatin dosing strategies when used with radiation on outcomes in head and neck squamous cell carcinoma of the oropharynx
    Meeting Abstract

    Tchekmedyian, V.; Ho, A. L.; Dunn, L.; Fetten, J. V.; Pfister, D. G.; Lobaugh, S.; Zhang, Z.; Kang, J.; Chen, L.; Riaz, N.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic adenoid cystic carcinoma (R/M ACC)
    Meeting Abstract

    Tchekmedyian, V.; Sherman, E. J.; Dunn, L.; Fetten, J. V.; Michel, L. S.; Kriplani, A.; Morris, L.; Ostrovnaya, I.; Katabi, N.; Haque, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Vemurafenib redifferentiation of BRAF mutant, RAI-refractory thyroid cancers
    Journal Article

    Dunn, L. A.; Sherman, E. J.; Baxi, S. S.; Tchekmedyian, V.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Journal of Clinical Endocrinology and Metabolism (2019)

    Fulltext@MSK | Save